Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ARMODAFINIL

ARMODAFINIL

Standard Dose
2500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview ARMODAFINIL is listed in Drugs@FDA under application 200156 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ARMODAFINIL Form and strength TABLET; ORAL - 2500MG Sponsor WATSON LABS INC Submission history Latest submission status date: 2017-01-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARMODAFINIL is listed in Drugs@FDA under application 200156 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ARMODAFINIL Form and strength TABLET; ORAL - 2500MG Sponsor WATSON LABS INC Submission history Latest submission status date: 2017-01-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.